Department of Human Metabolism and Nutrition, Braun School of Public Health, Hebrew University, Jerusalem, Israel.
Department of Clinical Science, Intervention and Technology, Karolinska Insitutet, Stockholm, Sweden.
Pediatr Diabetes. 2018 Dec;19(8):1351-1356. doi: 10.1111/pedi.12774. Epub 2018 Oct 1.
BACKGROUND/OBJECTIVE: Lifestyle modification is the therapy of choice for childhood obesity, yet the response rate is variable and may be affected by genetic factors. We aimed to investigate predictors of poor response to lifestyle modification obesity treatment in children.
A prospective cohort study of 434 youths (64.5% females) between 4 and 20 years of age undergoing a standard care of lifestyle modification obesity management for 35.9 ± 20.8 months at Yale Childhood Obesity Clinic, USA. The primary outcome was a "poor response," defined as the quintile with the largest increase in BMI Z-score over time. The secondary outcome was the endpoint BMI Z-score. Covariates investigated were sex, baseline pubertal status and degree of obesity, race, biochemical profile, and family history of overweight. A subsample (n = 214) had FTO genotyping (SNP rs8050136) tested.
Males (hazard ratio [HR] = 5.35, 95% confidence interval [CI] [3.32-8.61], P < 0.0001) and pubertal adolescents (HR = 2.78, [1.40-5.50], P = 0.003) compared to prepubertal children were more prone to respond poorly. Baseline degree of obesity was associated with relative protection from responding poorly (HR per BMI Z-score unit = 0.32, [0.17-0.61], P = 0.0006). Carriers of the FTO obesity-predisposing allele (AA genotype) were protected from responding poorly compared to non-carriers (CC genotype) (HR = 0.33, [0.12-0.88], P = 0.028).
Boys and pubertal adolescents are more prone to respond poorly to standard obesity care while those with greater baseline degree of obesity and carriers of the FTO obesity-predisposing allele are not.
背景/目的:生活方式改变是儿童肥胖症的首选治疗方法,但反应率各不相同,可能受到遗传因素的影响。我们旨在研究预测儿童生活方式改变肥胖治疗反应不良的因素。
这是在美国耶鲁儿童肥胖诊所进行的一项前瞻性队列研究,共有 434 名 4 至 20 岁的青少年(64.5%为女性)参与,他们接受了标准的生活方式改变肥胖管理治疗,治疗时间为 35.9±20.8 个月。主要结局是“反应不良”,定义为随着时间的推移 BMI Z 评分增加最大的五分位数。次要结局是终点 BMI Z 评分。研究的协变量包括性别、基线青春期状态和肥胖程度、种族、生化特征以及超重的家族史。一个亚组(n=214)进行了 FTO 基因分型(SNP rs8050136)检测。
与青春期前儿童相比,男性(风险比 [HR] = 5.35,95%置信区间 [CI] [3.32-8.61],P<0.0001)和青春期青少年(HR = 2.78,[1.40-5.50],P=0.003)更倾向于反应不良。基线肥胖程度与对反应不良的相对保护有关(每 BMI Z 评分单位的 HR = 0.32,[0.17-0.61],P=0.0006)。与非携带者(CC 基因型)相比,携带 FTO 肥胖易感等位基因(AA 基因型)的人对反应不良具有保护作用(HR=0.33,[0.12-0.88],P=0.028)。
男孩和青春期青少年更倾向于对标准肥胖治疗反应不良,而那些基线肥胖程度较高和携带 FTO 肥胖易感等位基因的人则不然。